• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ALAIR; BRONCHIAL THERMOPLASTY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ALAIR; BRONCHIAL THERMOPLASTY SYSTEM Back to Search Results
Model Number M005ATS25010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Asthma (1726); Fever (1858); Headache (1880); Pain (1994); Discomfort (2330); Respiratory Tract Infection (2420)
Event Date 05/05/2014
Event Type  Injury  
Manufacturer Narrative
The clinical patient id is (b)(6).The complainant was unable to provide the device lot number.Therefore, the manufacture and expiration dates are unknown.However, the complainant stated that the device was used prior to the expiration date.Study source: (b)(6) study.(b)(4).According to the complainant, the suspect device has been disposed and is not available for return.If any further relevant information is received, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an alair bronchial thermoplasty (bt) catheter was used during a bronchial thermoplasty procedure performed on (b)(6) 2014 as part of the (b)(6) study.On (b)(6) 2014, the patient underwent the first bronchial thermoplasty procedure performed in the right lower lobe of the lungs.No issues noted with the device.According to the complainant, on (b)(6) 2014, the patient experienced fever of >38 degrees celsius with symptoms of shaking chills and sweats following the bronchial thermoplasty treatment and was treated with tylenol.On (b)(6) 2014, the patient experienced asthma exacerbation with symptoms of wheezing and coughing and was treated with prednisone.On (b)(6) 2014, the patient experienced upper respiratory tract infection.The event was reported to be continuing, however, no intervention was needed.Additionally, the patient's fever resolved.On (b)(6) 2014, the patient recovered from the asthma exacerbation.No hospitalizations or emergency room visits occurred as a result of these events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALAIR
Type of Device
BRONCHIAL THERMOPLASTY SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
cork business technology park
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key8846548
MDR Text Key152804491
Report Number3005099803-2019-03620
Device Sequence Number1
Product Code OOY
UDI-Device Identifier08714729802792
UDI-Public08714729802792
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P080032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM005ATS25010
Device Catalogue NumberATS 2-5
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/10/2019
Initial Date FDA Received07/31/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age25 YR
Patient Weight86
-
-